Rare diseases
Investigational molecules
Locations
Bezrucova 5, Stare Mesto, 811 09 Bratislava, Slovakia
Cliniq s.r.o. in Bratislava, Slovakia specialises in clinical trials of conditions such as Colitis ulcerative, Crohn's disease, Hidradenitis, Hypertriglyceridaemia, and other specialisations. This site conducts important research.
The Bratislava‑based facility is focusing on Ulcerative Colitis research, aiming to test new therapies that reduce bowel urgency and achieve endoscopic remission.
Cliniq s.r.o. currently manages eight clinical studies with eleven investigators, contributing to advances in Digestive System Diseases across Europe.
Researchers are exploring innovative approaches for Atopic Dermatitis, including flexible dosing strategies to enhance skin clearance and maintain safety.
With eight active trials, the site’s team of eleven investigators is advancing treatment options for Immune System Diseases in the region.
The clinic conducts studies on Rheumatoid Arthritis, evaluating novel biologic agents to improve disease activity scores and patient outcomes.
Cliniq s.r.o.’s eight trials and eleven investigators reflect a strong commitment to progress in Musculoskeletal Diseases research.
More sites in BratislavaSlovakia
Clinical trials currently enrolling participants at this site.
SlovakiaStudy of LY4268989 adipic acid in adults with moderately to severely active ulcerative colitis
SlovakiaLong‑Term Safety and Efficacy of SPY001-001, SPY002 and SPY003 in Adults with Ulcerative Colitis
SlovakiaA study to evaluate the effectiveness and safety of duvakitug in patients with moderate to severe Crohn's disease
SlovakiaA study to evaluate the efficacy and safety of duvakitug in patients with moderate to severe Crohn's disease
SlovakiaA Study of Long-acting Antibodies SPY001-001 and SPY002 Alone and Combined for Adults with Moderate to Severe Ulcerative Colitis
SlovakiaA study of duvakitug for patients with moderately to severely active ulcerative colitis to see if it works and is safe as maintenance therapy
SlovakiaA study testing duvakitug for patients with moderately to severely active ulcerative colitis
SlovakiaStudy of laroprovstat (AZD0780) to reduce heart attack, stroke and vascular complications in patients with atherosclerotic cardiovascular disease or high risk of developing it
SlovakiaStudy of tulisokibart compared to placebo in adults with moderate to severe Crohn's disease
SlovakiaStudy on Long-term Safety of Zasocitinib for Adults with Moderate to Severe Ulcerative Colitis and Crohn's Disease
SlovakiaStudy of RO7790121 (afimkibart) for Treatment and Long-term Management in Adults with Moderate to Severe Crohn's Disease
SlovakiaGet verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
